Provided by Tiger Fintech (Singapore) Pte. Ltd.

Conduit Pharmaceuticals Inc.

2.00
-0.1000-4.76%
Post-market: 2.100.0996+4.98%19:57 EDT
Volume:115.08K
Turnover:234.97K
Market Cap:4.81M
PE:-0.01
High:2.13
Open:2.10
Low:2.00
Close:2.10
Loading ...
Aug 16, 2024

Major Issues Report

Form 8-K - Current report
Aug 13, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Aug 13, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 08, 2024

Major Issues Report

Form 8-K - Current report
Aug 08, 2024

Major Issues Report

Form 8-K - Current report
Jul 11, 2024

Major Issues Report

Form 8-K/A - Current report: [Amend]
Jul 02, 2024

Major Issues Report

Form 8-K - Current report
May 31, 2024

Major Issues Report

Form 8-K - Current report
May 14, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 17, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Apr 16, 2024

Major Issues Report

Form 8-K - Current report
Feb 09, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 03, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Jan 11, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Dec 14, 2023

Correspondence

Form CORRESP - Correspondence
Dec 02, 2023

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Dec 02, 2023

Correspondence

Form CORRESP - Correspondence
Dec 01, 2023

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Nov 21, 2023

[Rev.]Quaterly Report

Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
Nov 21, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]